Yesterday we described the burgeoning bribery allegations against GSK’s China operations in a post titled “Enemy at the Gates: Bribery Charges in China Getting Worse for GSK.“   Apparently, GSK’s China woes are getting worse by the day.  A Reuters artcile reports that the Chinese government has secured “confessions” from several GSK “executives” to bribery and tax violations.  (Click   http://www.reuters.com/article/2013/07/11/gsk-china-idUSL4N0FH21620130711 to read the Reuters story).

Allegations reported recently in the Wall Street Journal disclose that GSK Chinese staffers developed a plan, dubbed the “Vasily” program after famed World War II Russian sniper, Vasily Zaytsev, that targeted 48 doctors for payments and gifts in exchange for writing GSK drug prescriptions.   Pharmarisc will be following this story and will report any significant developments in the case.